Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 240 | 1,214 | 3,032 | 12,374 | 2,380 |
| Cost of Goods | -11 | 11 | N/A | 684 | 50 |
| Gross Profit | 251 | 1,203 | 3,032 | 11,690 | 2,330 |
| Operating Expenses | 173,683 | 119,631 | 142,579 | 129,524 | 233,684 |
| Operating Income | -173,443 | -118,417 | -139,547 | -117,150 | -231,304 |
| Other Income | 10,470 | 7,629 | 18,598 | 12,475 | 17,764 |
| Pre-tax Income | -162,973 | -110,788 | -120,949 | -104,675 | -213,540 |
| Income Tax | 168 | 170 | 16 | -86 | 177 |
| Net Income Continuous | -163,141 | -110,958 | -120,965 | -104,589 | -213,717 |
| Net Income | $-163,141 | $-110,958 | $-120,965 | $-104,589 | $-213,717 |
| EPS Basic Total Ops | -1.17 | -0.80 | -0.88 | -0.77 | -1.56 |
| EPS Basic Continuous Ops | -1.17 | -0.80 | -0.88 | -0.77 | -1.56 |
| EPS Diluted Total Ops | -1.17 | -0.80 | -0.88 | -0.77 | -1.56 |
| EPS Diluted Continuous Ops | -1.17 | -0.80 | -0.88 | -0.77 | -1.56 |
| EPS Diluted Before Non-Recurring Items | -1.17 | -0.80 | -0.88 | -0.76 | -1.56 |
| EBITDA(a) | $-169,130 | $-112,979 | $-132,591 | $-112,096 | $-228,054 |